Zobrazeno 1 - 10 of 11 pro vyhledávání: '"Uwe Haag"'
1
Olmesartan Medoxomil plus Amlodipine Increases Efficacy in Patients with Moderate-to-Severe Hypertension after Monotherapy
Autor: Carlos Escobar, Uwe Haag, Alberto Calderón, Peter Brommer, Vivencio Barrios
Publikováno v: Clinical Drug Investigation. 29:427-439
Background and objective: Hypertension remains a major global health problem, and evidence suggests that the majority of patients will require two or more antihypertensive agents in order to reach specified BP targets. Combining two drugs from differ
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99074d1d0eac5422b98358edc721f36c
https://doi.org/10.2165/00044011-200929070-00001
Zobrazit plný text záznamu
2
Original Research: Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study
Autor: Klaus O, Stumpe, Enrico, Agabiti-Rosei, Tomasz, Zielinski, Dieter, Schremmer, Jürgen, Scholze, Petra, Laeis, Peter, Schwandt, Malte, Ludwig, Uwe, Haag
Publikováno v: Therapeutic Advances in Cardiovascular Disease. 1:97-106
Objective The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study was a double-blind trial in patients with hypertension at increased cardiovascular risk with carotid wall thickening and a defined atherosclerotic plaque that use
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2d376f18cadd363cd1b01d40c4ba741
https://doi.org/10.1177/1753944707085982
Zobrazit plný text záznamu
3
Technologies for Automating Randomized Treatment Assignment in Clinical Trials
Autor: Uwe Haag
Publikováno v: Drug Information Journal. 32:7-11
Randomly assigning patients is considered the choice in clinical trials when comparing different treatments. Automatic treatment assignment systems have been developed in order to reduce costs, increase reliability, or to provide 24-hour service. Com
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1409f5b02938ced5caca109c71edc8e0
https://doi.org/10.1177/009286159803200102
Zobrazit plný text záznamu
5
A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients
Autor: Walter Paulus, Bernhard G. Weiss, Beate Schlotter-Weigel, Moritz J. Rossner, Axel Klink, Michael W. Sereda, Maggie C. Walter, Ruth M. Stassart, Tuuli J. Schnizer, Uwe Haag, Sven P. Wichert, Robert Fledrich, Gerd Meyer zu Hörste, Bernd Rautenstrauss
Publikováno v: Brain : a journal of neurology. 135(Pt 1)
Charcot-Marie-Tooth disease is the most common inherited neuropathy and a duplication of the peripheral myelin protein 22 gene causes the most frequent subform Charcot-Marie-Tooth 1A. Patients develop a slowly progressive dysmyelinating and demyelina
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4da3fb18b1296346396f6efd1f34dd94
https://pubmed.ncbi.nlm.nih.gov/22189569
Zobrazit plný text záznamu
6
Why and How to Build a Simple Statistical Computing System
Autor: Armin Koch, Werner Vach, Uwe Haag
Publikováno v: Computational Statistics & Data Analysis. 16:237-244
Many occasional users of statistical analysis systems work with only a limited number of simple statistical methods. In addition, they are often inexperienced in statistical data analysis or even in the use of computers. They are interested in an eas
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9857a92dd70989089cbd77ede74b5d44
https://doi.org/10.1016/0167-9473(93)90118-d
Zobrazit plný text záznamu
7
Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study
Autor: Cristina Miele, Uwe Haag, Massimo Volpe
Publikováno v: Clinical drug investigation. 29(6)
Treatment guidelines recommend combination therapy to control blood pressure (BP) in the majority of hypertensive patients. This long-term open-label study assessed a treatment algorithm based on olmesartan medoxomil (hereafter olmesartan), amlodipin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43d08b0da3924261e8554c9142a34eb6
https://pubmed.ncbi.nlm.nih.gov/19432498
Zobrazit plný text záznamu
8
Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine Monotherapy A Randomized, Double-Blind, Parallel-Group, Multicentre Study
Autor: Cristina Miele, Peter Brommer, Uwe Haag, Massimo Volpe
Background and objectives: Cerebrovascular and cardiac adverse events can be significantly reduced by effective antihypertensive therapy; however, BP control rates remain poor. The objective of this randomized, double-blind, parallel-group, multicent
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb38e706733dc109312677178219f870
http://hdl.handle.net/11573/82559
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje